3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
50
Phase 1
38
Phase NA
17
Phase 1/2
12
Phase 3
9
Phase EARLY_PHASE1
2
Phase 4
2
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Breast Neoplasms
276
Neoplasms
202
Prostatic Neoplasms
118
Polycystic Ovary Syndrome
114
Colorectal Neoplasms
103
Carcinoma, Hepatocellular
103
Carcinoma, Non-Small-Cell Lung
88
Lung Neoplasms
70
Stomach Neoplasms
62
Precursor Cell Lymphoblastic Leukemia-Lymphoma
60
Pain
59
Neoplasm Metastasis
54
Multiple Myeloma
52
Pancreatic Neoplasms
46
Keratosis, Actinic
46
Head and Neck Neoplasms
43
Pain, Postoperative
42
Leukemia, Myeloid, Acute
40
Leiomyoma
39
Recurrence
38
Liver Neoplasms
38
Colonic Neoplasms
37
Uterine Cervical Neoplasms
35
Lymphoma
35
Brain Neoplasms
34
Infertility
33
Papillomavirus Infections
32
Ovarian Neoplasms
31
Lymphoma, Follicular
31
Lymphoma, Non-Hodgkin
30
Interventions
Ritonavir
1
Nevirapine
1
Lopinavir
1
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
Emtricitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Interventional
×
Sarcoma, Kaposi
×
Clear all
NCT00444379
2014-08-20
ARKS
University of California, San Francisco
Phase 4
Completed
224 enrolled
NCT00380770
2010-07-21
KAART
University of KwaZulu
Phase 4
Completed
112 enrolled